Location History:
- Montclair, NJ (US) (2012 - 2019)
- San Carlos, CA (US) (2023)
Company Filing History:
2 out of 1,309 
2 out of 4,455 
1 out of 5 
Years Active: 2012-2023
Title: The Innovations of Hans-Peter Gerber
Introduction
Hans-Peter Gerber is a notable inventor based in Montclair, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies and methods for cancer detection. With a total of four patents to his name, Gerber's work has the potential to impact cancer diagnosis and treatment.
Latest Patents
Among his latest patents, Gerber has developed anti-EDB antibodies and antibody-drug conjugates. This invention provides antibodies that bind to the extra domain B splice variant of fibronectin 1, along with methods for preparing and utilizing these antibodies. Additionally, he has patented methods for detecting 5T4-positive circulating tumor cells in a mammalian subject. These methods are crucial for diagnosing 5T4-positive cancer, indicating the presence of metastatic or early-stage cancer.
Career Highlights
Throughout his career, Gerber has worked with prominent companies such as Wyeth and Pfizer Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of cancer treatment.
Collaborations
Some of his notable coworkers include Kimberly Ann Marquette and John Francis DiJoseph. Their collaboration has likely fostered an environment of innovation and shared expertise in their respective fields.
Conclusion
Hans-Peter Gerber's contributions to biotechnology and cancer research through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical diagnostics and treatment options.